240 related articles for article (PubMed ID: 36401052)
1. The Mechanism of SNHG8/Microrna-421-3p/Sorting Nexin 8 Axis on Dopaminergic Neurons in Substantia Nigra in a Mouse Model of Parkinson's Disease.
Zhou S; Zhou X; Jiang Z; Ma J; Li Y; Qian Z; Li H
Neurochem Res; 2023 Mar; 48(3):942-955. PubMed ID: 36401052
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
Kanagaraj N; Beiping H; Dheen ST; Tay SS
Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
[TBL] [Abstract][Full Text] [Related]
3. HOTAIR drives autophagy in midbrain dopaminergic neurons in the substantia nigra compacta in a mouse model of Parkinson's disease by elevating NPTX2
Lang Y; Li Y; Yu H; Lin L; Chen X; Wang S; Zhang H
Aging (Albany NY); 2020 May; 12(9):7660-7678. PubMed ID: 32396526
[TBL] [Abstract][Full Text] [Related]
4. MALAT1 Mediates
Geng X; Zou Y; Li S; Qi R; Yu H; Li J
Mediators Inflamm; 2023; 2023():4477492. PubMed ID: 37064502
[TBL] [Abstract][Full Text] [Related]
5. LncRNA H19 diminishes dopaminergic neuron loss by mediating microRNA-301b-3p in Parkinson's disease via the HPRT1-mediated Wnt/β-catenin signaling pathway.
Jiang J; Piao X; Hu S; Gao J; Bao M
Aging (Albany NY); 2020 May; 12(10):8820-8836. PubMed ID: 32434961
[TBL] [Abstract][Full Text] [Related]
6. miR-101a-3p/ROCK2 axis regulates neuronal injury in Parkinson's disease models.
Tao X; Zhang W; Chen C; Tao Y; Tao Y; Chen Z; Zhang G
Aging (Albany NY); 2024 May; 16(10):8732-8746. PubMed ID: 38775730
[TBL] [Abstract][Full Text] [Related]
7. circ-Pank1 promotes dopaminergic neuron neurodegeneration through modulating miR-7a-5p/α-syn pathway in Parkinson's disease.
Liu Q; Li Q; Zhang R; Wang H; Li Y; Liu Z; Xie W; Geng D; Wang L
Cell Death Dis; 2022 May; 13(5):477. PubMed ID: 35589691
[TBL] [Abstract][Full Text] [Related]
8. miR-214-3p promotes the pathogenesis of Parkinson's disease by inhibiting autophagy.
Dong H; Yan J; Huang P; Wang X; Zhang R; Zhang C; Wang W; Qian W; Zhou J; Zhao Y; Gao J; Zhang M; Ma X; Wang Z; Yi C; Zhang J; Chen W
Biomed Pharmacother; 2024 Feb; 171():116123. PubMed ID: 38211424
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective microRNA-381 Binds to Repressed Early Growth Response 1 (EGR1) and Alleviates Oxidative Stress Injury in Parkinson's Disease.
Guo S; Gao Y; Zhao Y
ACS Chem Neurosci; 2023 Jun; 14(11):1981-1991. PubMed ID: 37166273
[TBL] [Abstract][Full Text] [Related]
10. microRNA-221 rescues the loss of dopaminergic neurons in a mouse model of Parkinson's disease.
Yao Y; Zhao Z; Zhang F; Miao N; Wang N; Xu X; Yang C
Brain Behav; 2023 Mar; 13(3):e2921. PubMed ID: 36795044
[TBL] [Abstract][Full Text] [Related]
11. Dopaminergic neuron injury in Parkinson's disease is mitigated by interfering lncRNA SNHG14 expression to regulate the miR-133b/ α-synuclein pathway.
Zhang LM; Wang MH; Yang HC; Tian T; Sun GF; Ji YF; Hu WT; Liu X; Wang JP; Lu H
Aging (Albany NY); 2019 Nov; 11(21):9264-9279. PubMed ID: 31683259
[TBL] [Abstract][Full Text] [Related]
12. Suppression of microRNA-342-3p increases glutamate transporters and prevents dopaminergic neuron loss through activating the Wnt signaling pathway via p21-activated kinase 1 in mice with Parkinson's disease.
Wu DM; Wang S; Wen X; Han XR; Wang YJ; Shen M; Fan SH; Zhuang J; Zhang ZF; Shan Q; Li MQ; Hu B; Sun CH; Lu J; Chen GQ; Zheng YL
J Cell Physiol; 2019 Jun; 234(6):9033-9044. PubMed ID: 30362546
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of lncRNA BACE1-AS improves dopamine-dependent oxidative stress in rats with Parkinson's disease by upregulating microRNA-34b-5p and downregulating BACE1.
Li Y; Fang J; Zhou Z; Zhou Q; Sun S; Jin Z; Xi Z; Wei J
Cell Cycle; 2020 May; 19(10):1158-1171. PubMed ID: 32308102
[No Abstract] [Full Text] [Related]
14. DJ-1 protects dopaminergic neurons against rotenone-induced apoptosis by enhancing ERK-dependent mitophagy.
Gao H; Yang W; Qi Z; Lu L; Duan C; Zhao C; Yang H
J Mol Biol; 2012 Oct; 423(2):232-48. PubMed ID: 22898350
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-185 activates PI3K/AKT signalling pathway to alleviate dopaminergic neuron damage via targeting IGF1 in Parkinson's disease.
Qin X; Zhang X; Li P; Wang M; Yan L; Pan P; Zhang H; Hong X; Liu M; Bao Z
J Drug Target; 2021 Sep; 29(8):875-883. PubMed ID: 33560148
[TBL] [Abstract][Full Text] [Related]
16. Circular RNA circTLK1 regulates dopaminergic neuron injury during Parkinson's disease by targeting miR-26a-5p/DAPK1.
Chen W; Hou C; Wang Y; Hong L; Wang F; Zhang J
Neurosci Lett; 2022 Jun; 782():136638. PubMed ID: 35447224
[TBL] [Abstract][Full Text] [Related]
17. miR-29c-3p regulates TET2 expression and inhibits autophagy process in Parkinson's disease models.
Wang R; Yao J; Gong F; Chen S; He Y; Hu C; Li C
Genes Cells; 2021 Sep; 26(9):684-697. PubMed ID: 34086379
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA GAS5 promotes microglial inflammatory response in Parkinson's disease by regulating NLRP3 pathway through sponging miR-223-3p.
Xu W; Zhang L; Geng Y; Liu Y; Zhang N
Int Immunopharmacol; 2020 Aug; 85():106614. PubMed ID: 32470877
[TBL] [Abstract][Full Text] [Related]
19. Regulatory Mechanism of miR-543-3p on GLT-1 in a Mouse Model of Parkinson's Disease.
Wu X; Meng X; Tan F; Jiao Z; Zhang X; Tong H; He X; Luo X; Xu P; Qu S
ACS Chem Neurosci; 2019 Mar; 10(3):1791-1800. PubMed ID: 30676715
[TBL] [Abstract][Full Text] [Related]
20. miR-425 deficiency promotes necroptosis and dopaminergic neurodegeneration in Parkinson's disease.
Hu YB; Zhang YF; Wang H; Ren RJ; Cui HL; Huang WY; Cheng Q; Chen HZ; Wang G
Cell Death Dis; 2019 Aug; 10(8):589. PubMed ID: 31383850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
